Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Nicotinic acetylcholine receptors (nAChRs) are diverse members of the neurotransmitter‐gated ion channel superfamily and play critical roles in chemical signaling throughout the nervous system. The present study establishes for the first time the acute functional effects of sertraline (Zoloft), paroxetine (Paxil), nefazodone (Serzone), and venlafaxine (Effexor) on two human and one chick nAChR subtype. This study also confirms previous findings of nAChR functional block by fluoxetine (Prozac). Function of human muscle‐type nAChR (α1βγδ) in TE671/RD cells, human autonomic nAChR (α3β4α5 ±β2) in SH‐SY5Y neuroblastoma cells, or chick V274T mutant α7‐nAChR heterologously expressed in native nAChR‐null SH‐EP1 epithelial cells was measured using 86 Rb+ efflux assays. Functional blockade of human muscle‐type and autonomic nAChRs is produced by each of the drugs in the low to intermediate micromolar range, and functional blockade of chick V274T‐α7‐nAChR is produced in the intermediate to high micromolar range. Functional blockade is insurmountable by increasing agonist concentrations at each nAChR subtype tested for each of these drugs, suggesting noncompetitive inhibition of nAChR function. These studies open the possibilities that nAChR subtypes in the brain could be targets for therapeutic antidepressants and could play roles in clinical depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207
Le Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385
Fryer, J. D., & Lukas, R. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37928-5 · Cited by 283
Self-citationNicotinic acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices
Hennings, E. C. P., Kiss, J. P., & Vizi, E. S. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00343-0 · Cited by 55
Depression and the Dynamics of Smoking: A National Perspective
Anda, R. F. (1990) · JAMA · doi:10.1001/jama.1990.03450120053028 · Cited by 28
Cited by
Neuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970
Neuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 782
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Taly, A., Corringer, P.-J., Guedin, D., Lestage, P., & Changeux, J.-P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 703
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Effect of nicotine and nicotinic receptors on anxiety and depression
Picciotto, M. R., Brunzell, D. H., & Caldarone, B. J. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00006 · Cited by 483
Metadata
- Authors
- Fryer, J. D., & Lukas, R. J.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1999-03
- Volume
- 72
- Issue
- 3
- Pages
- 1117-1124
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2020194725
- Cited by
- 137
- References
- 5
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function. https://app.cochat.ai/papers/10.1046/j.1471-4159.1999.0721117.x
- The paper
- Fryer, J. D., & Lukas, R. J. (1999). Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.1999.0721117.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.